Bharat Biotech to use ViroVax's adjuvant in Covid vaccine
Posted by
www.biotecnika.org
Bharat Biotech has teamed up with ViroVax to use the US scientific
research firm's adjuvant for boosting the immune response and
providing long-lasting immunity to its novel vaccine candidate
Covaxin, which has entered phase-2 human trials.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-to-use-virovaxs-adjuvant-in-covid-vaccine/articleshow/78505253.cms
Subscribe to:
Post Comments (Atom)
Post a Comment